IGF1R and cancer: Thus, cancer cells adapt very rapidly to PI3K inhibition, mainly due to feedback signals leading to activation or enhanced expression of growth factor receptors, such as IR/IRS1/IGF-1R, which, in turn, reactivate PI3K [42,43].